Published February 1987 | Version v1
Journal article

Immunoprotective and leukopoiesis-stimulating effects of 10-hydroxy-Δ2-decenoic acid in patients under radiotherapy

  • 1. Suzhou Medical Coll., JS (China). First Affiliated Hospital

Description

10-Hydroxy-Δ2-decenoic acid(10-HDA) is an unique fatty acid component in royal jelly. It was used in randomized trials in 52 patients with malignant tumors. The synthesis of DNA in their T-lymphocytes induced by PHA was investigated by the determination of 3H-TdR incorporation. Comparison of preirradiation 'cpm' values between <60 Gy, 90∼100 Gy and >100 Gy dose groups showed no significant difference in degree of T-lymphocytes depression in the patients of treated groups. In the control group, however, 'cpm' values increased progressively with the increasing radiation dose. The results demonstrated that 10-HDA might have antiirradiation and immunoprotective effects during radiotherapy. It is concluded that 10-HDA is one of the safer and more effective adjuvant drugs in radiotherapy

Additional details

Publishing Information

Journal Title
Chin. J. Radiol. Med. Prot.
Journal Volume
7
Journal Issue
1
Series
Chin. J. Radiol. Med. Prot.
Journal Page Range
40-42
ISSN
0254-5098
CODEN
ZFYZD